153 related articles for article (PubMed ID: 6888378)
21. Shortage of mitogen-activated protein kinase is responsible for resistance to AP-1 transactivation and transformation in mouse JB6 cells.
Huang C; Ma WY; Young MR; Colburn N; Dong Z
Proc Natl Acad Sci U S A; 1998 Jan; 95(1):156-61. PubMed ID: 9419345
[TBL] [Abstract][Full Text] [Related]
22. The role of glycogen synthase kinase 3beta in the transformation of epidermal cells.
Ma C; Wang J; Gao Y; Gao TW; Chen G; Bower KA; Odetallah M; Ding M; Ke Z; Luo J
Cancer Res; 2007 Aug; 67(16):7756-64. PubMed ID: 17699780
[TBL] [Abstract][Full Text] [Related]
23. Dominant-negative c-Jun (TAM67) target genes: HMGA1 is required for tumor promoter-induced transformation.
Dhar A; Hu J; Reeves R; Resar LM; Colburn NH
Oncogene; 2004 May; 23(25):4466-76. PubMed ID: 15064752
[TBL] [Abstract][Full Text] [Related]
24. Membrane and genetic events in tumor promotion: studies with promoter resistant variants of JB6 cells.
Colburn NH; Lerman MI; Srinivas L; Nakamura Y; Gindhart TD
Princess Takamatsu Symp; 1983; 14():155-66. PubMed ID: 6394588
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of tumor promoter-induced transformation by retinoids that transrepress AP-1 without transactivating retinoic acid response element.
Li JJ; Dong Z; Dawson MI; Colburn NH
Cancer Res; 1996 Feb; 56(3):483-9. PubMed ID: 8564958
[TBL] [Abstract][Full Text] [Related]
26. Promotion-sensitive epidermal and mammary epithelial cells maintained in suspension over agarose.
Eto I
Cell Prolif; 1998 Apr; 31(2):71-92. PubMed ID: 9745617
[TBL] [Abstract][Full Text] [Related]
27. Induction of anchorage-independent growth of JB6 mouse epidermal cells by 1 alpha,25-dihydroxyvitamin D3.
Hosoi J; Abe E; Suda T; Colburn NH; Kuroki T
Cancer Res; 1986 Nov; 46(11):5582-6. PubMed ID: 3019530
[TBL] [Abstract][Full Text] [Related]
28. Enhancing mitochondrial respiration suppresses tumor promoter TPA-induced PKM2 expression and cell transformation in skin epidermal JB6 cells.
Wittwer JA; Robbins D; Wang F; Codarin S; Shen X; Kevil CG; Huang TT; Van Remmen H; Richardson A; Zhao Y
Cancer Prev Res (Phila); 2011 Sep; 4(9):1476-84. PubMed ID: 21673231
[TBL] [Abstract][Full Text] [Related]
29. Tumor promoters and epidermal growth factor stimulate anchorage-independent growth of adenovirus-tranformed rat embryo cells.
Fisher PB; Bozzone JH; Weinstein IB
Cell; 1979 Nov; 18(3):695-705. PubMed ID: 316362
[TBL] [Abstract][Full Text] [Related]
30. Possible involvement of a lanthanide-sensitive protein kinase C substrate in lanthanide promotion of neoplastic transformation.
Smith BM; Gindhart TD; Colburn NH
Carcinogenesis; 1986 Dec; 7(12):1949-56. PubMed ID: 3096584
[TBL] [Abstract][Full Text] [Related]
31. Osteopontin mediates tumorigenic transformation of a preneoplastic murine cell line by suppressing anoikis: an Arg-Gly-Asp-dependent-focal adhesion kinase-caspase-8 axis.
Hsieh YH; van der Heyde H; Oh ES; Guan JL; Chang PL
Mol Carcinog; 2015 May; 54(5):379-92. PubMed ID: 24249517
[TBL] [Abstract][Full Text] [Related]
32. Early superoxide dismutase-sensitive event promotes neoplastic transformation in mouse epidermal JB6 cells.
Nakamura Y; Gindhart TD; Winterstein D; Tomita I; Seed JL; Colburn NH
Carcinogenesis; 1988 Feb; 9(2):203-7. PubMed ID: 2827903
[TBL] [Abstract][Full Text] [Related]
33. AP1/jun function is differentially induced in promotion-sensitive and resistant JB6 cells.
Bernstein LR; Colburn NH
Science; 1989 May; 244(4904):566-9. PubMed ID: 2541502
[TBL] [Abstract][Full Text] [Related]
34. Comparison of mouse pro-1 and pro-2 transfectants for responses to tumor promoters and antipromoters.
Colburn NH; Smith BM; Wendel EJ; Nakamura Y; Winterstein D
Cancer Res; 1988 Nov; 48(21):6076-80. PubMed ID: 3139288
[TBL] [Abstract][Full Text] [Related]
35. Cellular dichotomy between anchorage-independent growth responses to bFGF and TPA reflects molecular switch in commitment to carcinogenesis.
Waters KM; Tan R; Opresko LK; Quesenberry RD; Bandyopadhyay S; Chrisler WB; Weber TJ
Mol Carcinog; 2009 Nov; 48(11):1059-69. PubMed ID: 19526458
[TBL] [Abstract][Full Text] [Related]
36. Effect of curcumin on 12-O-tetradecanoylphorbol-13-acetate- and ultraviolet B light-induced expression of c-Jun and c-Fos in JB6 cells and in mouse epidermis.
Lu YP; Chang RL; Lou YR; Huang MT; Newmark HL; Reuhl KR; Conney AH
Carcinogenesis; 1994 Oct; 15(10):2363-70. PubMed ID: 7955078
[TBL] [Abstract][Full Text] [Related]
37. 1 alpha,25-Dihydroxyvitamin D3 enhances 12-O-tetradecanoylphorbol-13-acetate- induced tumorigenic transformation and osteopontin expression in mouse JB6 epidermal cells.
Chang PL; Prince CW
Cancer Res; 1993 May; 53(10 Suppl):2217-20. PubMed ID: 8485706
[TBL] [Abstract][Full Text] [Related]
38. Synergistic inhibition of phorbol ester-induced transformation of JB6 cells by transforming growth factor-beta and retinoic acid.
De Benedetti F; Falk L; Ruscetti FW; Colburn NH; Faltynek CR; Oppenheim JJ
Cancer Res; 1991 Feb; 51(4):1158-64. PubMed ID: 1847657
[TBL] [Abstract][Full Text] [Related]
39. Gene regulation and genetic susceptibility to neoplastic transformation: AP-1 and p80 expression in JB6 cells.
Bernstein LR; Ben-Ari ET; Simek SL; Colburn NH
Environ Health Perspect; 1991 Jun; 93():111-9. PubMed ID: 1773784
[TBL] [Abstract][Full Text] [Related]
40. Transformation nonresponsive cells owe their resistance to lack of p65/nuclear factor-kappaB activation.
Hsu TC; Nair R; Tulsian P; Camalier CE; Hegamyer GA; Young MR; Colburn NH
Cancer Res; 2001 May; 61(10):4160-8. PubMed ID: 11358840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
